T 1779/21 (Dravet syndrome/KATHOLIEKE UNIVERSITEIT LEUVEN) of 19.12.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T177921.20231219
- Date of decision
- 19 December 2023
- Case number
- T 1779/21
- Petition for review of
- -
- Application number
- 14724037.8
- IPC class
- A61K 45/06A61P 25/08A61K 31/137
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 083
- Application title
- Fenfluramine for use in the treatment of Dravet syndrome
- Applicant name
- Katholieke Universiteit Leuven
University Hospital Antwerp - Opponent name
- Teva Pharmaceutical Industries Ltd.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)
- Keywords
- Sufficiency of disclosure - (no)
- Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.